Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / stockholder-written-consent-form.docx
stockholder-written-consent-form.docx
Parties
Delaware General Corp
Harkness LLP
Penterra Pharmaceuticals Corp
Fidelis National Escrow Corp
Ridgeway Partners LLC
Cole LLP
Dates
June 10, 2024
June 7, 2024
Amounts
$900,000,000
$180,000,000
$2,500,000
$717,500,000
$9,000,000
Obligations
Each stockholder executing a counterpart of this Written Consent and Joinder Agreement must identify all classes and series of capital stock of the Company held by such stockholder as of the date hereof
Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Stock Purchase Agreement, which meanings are hereby incorporated by reference
NOW, THEREFORE, the Stockholder, intending to be legally bound, hereby consents to, approves, and agrees to the following: SECTION 1 — APPROVAL AND ADOPTION OF THE STOCK PURCHASE AGREEMENT AND THE TRANSACTIONS 1
The Stockholder's approval and adoption of the SPA shall constitute the Stockholder's written consent to the SPA and the Transactions within the meaning of Section 228 of the DGCL
The Stockholder acknowledges and agrees that the Net Closing Payment to the Sellers (calculated as the Purchase Price of $900,000,000, minus the Indemnification Escrow Amount of $180,000,000, minus the Expense Fund of $2,500,000, equaling Seven Hundred Seventeen Million Five Hundred Thousand Dollars ($717,500,000), subject to further adjustment as provided in the SPA) will be reduced by the Indemnification Escrow Amount and the Expense Fund, and that the Stockholder's pro rata share of such Net Closing Payment shall be determined in accordance with the allocation methodology set forth in the SPA
The Stockholder hereby agrees to be bound by the Stock Purchase Agreement as a "Seller" thereunder, with the same force and effect as if the Stockholder were an original signatory to the SPA